Fig. 2From: Ribosomal protein L34 is a potential prognostic biomarker and therapeutic target in hilar cholangiocarcinomaHeterogeneity of RPL34 expression in the same tumor. a RPL34 expression in a representative tumor sample; b1, b2 weak expression of RPL34 in a well-differentiated region; c1–d2 High expression of RPL34 in invasive tumor cells. a IHC × 40; b1–d1 IHC × 200Back to article page